Store
GS2 · Health

Watch on GLP-1 weight-loss drugs

1 min readHealth
Battle IAS current affairs title card: Watch on GLP-1 weight-loss drugs (GS2 · Health, 24 March 2026)

What happened

  • The Drugs Controller intensified surveillance against unauthorised sale and promotion of GLP-1 weight-loss drugs [PIB].

Background

  • Multiple generic versions have entered the market [PIB].

Why it matters

  • Cheap generics widen access but also misuse.

How to use this in Mains

GS-II Issues relating to development and management of health

  1. As per PIB (2026-03-24): the Drugs Controller intensified surveillance against unauthorised sale and promotion of GLP-1 weight-loss drugs.
  2. Cheap generics widen access but also misuse.
Quotable data point

The Drugs Controller intensified surveillance against unauthorised sale and promotion of GLP-1 weight-loss drugs.

PIB: GLP-1 surveillance, 24 Mar 2026

Exam angle

UPSC

Prelims: GLP-1.

Practice MCQs

Original practice questions (not PYQs).

Practice · UPSC

GLP-1 drugs are used for

Answer (b) & explanation

PIB.

Go deeper

ExplainerOne Health Approach: Why Human, Animal and Environmental Health Are Linked, Zoonotic Diseases, the Global Quadripartite and India’s National One Health Mission (UPSC Notes + PYQs)ExplainerAntimicrobial Resistance (AMR): How Superbugs Arise, the Global and Indian Burden, Causes in Hospitals, Farms and the Environment, and India’s National Action Plan 2.0 (UPSC Notes + PYQs)

Official source: PIB: GLP-1 surveillance, 24 Mar 2026

facts from cited sources only; faculty review pending